Adenosine

關於「Adenosine」標籤，搜尋引擎有相關的訊息討論：

Molecular cloning and characterization of an adenosine receptorRamkumar V, Pierson G, Stiles GL. Adenosine receptors: clinical implications and biochemical mechanisms. Prog Drug Res. 1988;32:195–247. tw | twMolecular Characterization of A1 and A2a Adenosine ReceptorsMolecular Characterization of A1 and A2a Adenosine Receptors ... article] [PubMed] [Google Scholar]; Olah ME, Ren H, Ostrowski J, Jacobson KA, Stiles GL. tw | twAdenosine receptors | Introduction - IUPHAR/BPS Guide to ...Fredholm BB, Frenguelli BG, Hills R, IJzerman AP, Jacobson KA, Klotz KN, Linden J, Müller CE, Schwabe U, Stiles GL. Adenosine receptors (version 2021.2) in the ...Identification of A2a Adenosine Receptor Domains Involved in ...Responses to adenosine are governed by selective activation of distinct G proteins by adenosine receptor (AR) ... Palmer T.M.; Gettys T.W.; Stiles G.L.Mast cell adenosine receptors function: a focus on the A3 - Frontiers2012年6月4日 · Four subtypes (A1, A2a, A2b, and A3) of adenosine receptors have been cloned and ... Palmer, T. M., Gettys, T. W., and Stiles, G. L. (1995).An emerging role for adenosine and its receptors in bone homeostasis2012年9月18日 · Within the cell ATP and adenosine are continually recycled depending on energy ... Fatokun, A. A., Stone, T. W., and Smith, R. A. (2006).A3 adenosine receptor stimulation modulates sarcoplasmic ...Objective: Stimulation of A3 adenosine receptors has been shown to protect cardiac myocytes from ischemic injury, ... [42] Palmer TM, Gettys TW, Stiles GL.Adenosine Receptors in Health and DiseaseMol Pharmacol 57:539–545 Palmer TM, Gettys TW, Jacobson KA, Stiles GL (1994) Desensitization of the canine A2a adenosine receptor: delineation of multiple ...Drug Discovery and Evaluation: Pharmacological AssaysMolecular cloning and functional expression of a sheep AS adenosine receptor has been ... Mol Pharmacol 45:978-982 Palmer TM, Gettys TW, Stiles GL (1995) ...Adenosine Receptors - Sigma-AldrichA synthetic adenosine receptor agonist might therefore be beneficial to the survival of the ischemic heart. A3 receptor agonists are also a target for cancer ...